$20.36+0.19 (+0.97%)
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
NRC Health in the Healthcare sector is trading at $20.36 with a market capitalization of $469M. Wall Street consensus targets $26.00 (1 analysts), implying a +27.7% move over the next 12 months. The stock is currently 14% below its 52-week high of $23.68, remaining 8.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $35.39Mβ | $34.80Mβ | $35.19Mβ | $34.61Mβ | $34.04M |
| Gross Profit | $21.83Mβ | $21.16Mβ | $21.26Mβ | $22.20Mβ | $21.06M |
| Operating Income | -$3.24Mβ | $5.57Mβ | $4.67Mβ | $7.74Mβ | $1.59M |
| Net Income | -$3.28Mβ | $3.22Mβ | $1.80Mβ | $4.12Mβ | -$106,000 |
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking o...